Navigation Links
Handheld probe shows great promise for oral cancer detection
Date:4/30/2012

A team of American researchers have created a portable, miniature microscope in the hope of reducing the time taken to diagnose oral cancer.

The probe, which is around 20 cm long and 1 cm wide at its tip, could be used by doctors to diagnose oral cancer in real-time or as a surgical guidance tool; dentists could also use it to screen for early-stage cancer cells.

The probe has been presented today, Friday 27 April, in IOP Publishing's Journal of Micromechanics and Microengineering, and has shown good agreement with images of oral cancers obtained using conventional, much slower techniques at the University of Texas Health Science Centre at San Antonio, TX.

Historically, the death rate associated with oral cancer is particularly high; not because it is hard to discover or diagnose, but due to the cancer being routinely discovered late in its development.

Lead author of the study Dr John X J Zhang at the University of Texas at Austin said: "Today, that statement is still true, as there isn't a comprehensive programme in the US to opportunistically screen for the disease; without that, late stage discovery is more common."

The probe uses a laser to illuminate areas of the sample and can view beneath the surface of tissue, creating full 3D images. It can also take a series of images and layer them on top of each other, much like the tiling of a mosaic, giving a large overall field-of-view.

The key component of the probe is a micromirror. Micromirrors have previously been used in barcode scanners and fibre optic switches and are controlled by a microelectromechanical system, allowing the laser beam to scan an area in a programmed fashion.

The low cost and ease of fabrication of micromirrors, along with their easy integration into electronic systems for versatile imaging operations, make them an indispensable component of the probe.

Oral cancers have traditionally been diagnosed by biopsy. Based on a doctor's visual inspection, medical practitioners remove a sample of tissue from the patient and send it off to a pathologist who will examine the tissue under a microscope to check for abnormal or malignant cells.

Results will be sent back to the doctor for the next round of diagnoses or surgery; the whole process can take up to several weeks. Not only is this process time consuming, it can be costly, invasive and painful, often leaving scars.

"Due to the lack of real-time efficient oral cancer screening tools, it is estimated that approximately $3.2 billion is spent in the United States each year on treatment of such cancers", Dr Zhang continued.

The researchers, from the University of Texas at Austin and the commercialization partner NanoLite Systems, Inc. are now planning clinical trials with a view to gaining approval from the Food and Drug Administration (FDA). They envisage that, with a few adjustments, the device could be built for a quarter of the price it costs to build the microscopes that are currently used in diagnosis, which is around $300 000.


'/>"/>
Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics
Source:Eurekalert  

Related biology technology :

1. Handheld plasma flashlight rids skin of notorious pathogens
2. Hothead Technologies Partners with Sivix Logistics to Add Customized Handheld Monitors and Autonomous Sensors to its Product Line
3. Novel handheld device detects anthrax with outstanding accuracy and reliability
4. Novel handheld device detects anthrax with outstanding accuracy and reliability
5. Independent U.S. Study Confirms Veritides Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability
6. HOGGAN Ergo Announces Highly Anticipated Enhancements to the ergoFET Handheld Digital Force Gauge, Greatly Impacting the Field of Ergonomic Research and Application
7. Gen-Probe Reports Financial Results for the Fourth Quarter of 2011
8. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
9. Gen-Probe Reports Financial Results for the Second Quarter of 2011
10. Dune Medicals MarginProbeâ„¢ Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re-excision in Landmark Lumpectomy Surgery Trial
11. Gen-Probe to Webcast Two Upcoming Investor Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Handheld probe shows great promise for oral cancer detection
(Date:1/16/2017)... 2017   Valentin A. Pavlov, PhD , associate ... and CEO of The Feinstein Institute for Medical ... how the nervous system regulates the immune system, which ... medicine devices to treat disease and injury. The ... The paper examines various studies which further ...
(Date:1/16/2017)... Jan. 16, 2017  Eurofins Genomics today announced the ... more customers to receive their primers in a shorter ... in quality found with other providers. Express oligos are ... at no additional fee. Researchers ... studies, including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. ...
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... Research and Markets has announced the addition of ... ... grow at a CAGR of 16.83% during the period 2017-2021. ... the global biopolymers market for 2017-2021. To calculate the market size, the ... products. The report also includes a a discussion of the key vendors ...
Breaking Biology Technology:
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):